HTA36 Robustness of Outcomes in Indirect Comparison Methods of Pegylated Liposomal Irinotecan for the Treatment of Metastatic Pancreatic Cancer in Patients Who Have Progressed Following Gemcitabine-Based Therapy
Abstract
Authors
J Felix Parreia V Andreozzi J Henriques AP Amorim M Massetti